Immuno-Biological Laboratories Co., Ltd.

Founded in 1982, Immuno-Biological Laboratories Co., Ltd (IBL) provides ISO 13485-certified solutions for pharmaceutical companies, diagnostic manufacturers, universities, hospitals, and biomedical research institutes.  IBL is a leading developer and manufacturer of high-quality antibodies, ELISA kits, assay reagents and biomarker solutions for life science and clinical research applications. IBL has established a strong reputation for developing unique immunoassays and specialised reagents supporting research in ageing, neurodegenerative diseases, kidney disease, inflammation, metabolism and cardiovascular health. 

IBL offers an extensive portfolio of validated ELISA kits, monoclonal antibodies and biomarker assays, including products for Neurofilament Light Chain (NfL), Phospho-Tau 217, α-Klotho, Glucagon, T-Cadherin, Uromodulin, Titin and Lipoprotein Lipase research. They also provide antibody development services, protein production technologies and specialised testing services for researchers worldwide. 

Cambridge Bioscience is pleased to provide IBL products in the UK and Ireland.

Your trusted supplier of ELISA Kits, Antibodies & Biomarker Assays : IBL

  ►Specialist biomarker assays for Alzheimer's disease, chronic kidney disease, diabetes, inflammation and other clinically relevant disease areas.

  ►Extensive range of validated ELISA kits. 

  ►High-quality monoclonal antibodies and immunoreagents. 

  ►Innovative products for translational research, helping to bridge the gap between discovery and application.

  ►ISO 13485-certified antibody manufacturing expertise.